MedPath

Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL)

Not Applicable
Completed
Conditions
Acute Leukemia
Registration Number
NCT01404520
Lead Sponsor
Universitetshospitalernes Center for Sygepleje
Brief Summary

The purpose of this study is to test a new preventive and restorative intervention for patients with acute leukaemia undergoing consolidation chemotherapy, to measure and delineate the patients' treatment related symptom burden and to explore the effect of the intervention on length of hospital stay, duration of sick leave and return to work status. Further, to examine the relationship of the symptom profile with clinical indicators, physiological response, physical performance and survival.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Patients that are able to speak Danish > 18 years and newly diagnosed with acute leukæmia (MDS, AML, CMML, APL or ALL)
  • Normal EKG, blood pressure and pulse
  • Signed informed written consent
Exclusion Criteria
  • Medical reason that contraindicates physical activity
  • Patients diagnosed with a symptomatic cardial disease
  • Documented bone metastasis
  • Cognitively or emotionally unstable
  • Unable to read or write in Danish
  • Patients unable to carry out baseline tests

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Six Minute Walk Distance 6MWDChange from baseline in 6MWD at 12 weeks

Change in distance in meter

Secondary Outcome Measures
NameTimeMethod
Estimated VO2 max Aastrand testChange from baseline in VO2 Aastrand test at 12 weeks

Change in l/m

Timed chair standChange from baseline in timed chair stand at 12 weeks

Change in number of repetitions

Timed biceps curlChange from baseline in timed bicep curl at 12 weeks

Change in number of repetitions

EORTC QLQ-C30Change from baseline in EORTC QLQ-C30 at 12 weeks

Change in scores for quality of life

FACT-AnChange from baseline in FACT-An at 12 weeks

Change in scores for quality of life/function

HADSChange from baseline in HADS at 12 weeks

Change in scores for emotional wellbeing

SF36Change from baseline in SF36 at 12 weeks

Change in scores for general health

MDASIChange from baseline over time (1,2,3,4,5,6,7,8,9,10,11,12 weeks)

Change in scores for symptom burden

Trial Locations

Locations (2)

Copenhagen University Hospital Rigshospital

🇩🇰

Copenhagen, Denmark

Herlev Hospital

🇩🇰

Herlev, Denmark

Copenhagen University Hospital Rigshospital
🇩🇰Copenhagen, Denmark

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.